Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations.

Young, Allan H; Abdelghani, Mohamed; Juruena, Mario F; Nikolova, Viktoriya L; Nilforooshan, Ramin

Young, Allan H; Abdelghani, Mohamed; Juruena, Mario F; Nikolova, Viktoriya L; Nilforooshan, Ramin.

Afiliação

Young AH; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Abdelghani M; Camden and Islington NHS Foundation Trust, London, UK.
Juruena MF; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Nikolova VL; Maudsley Advanced Treatment Service (MATS), South London and Maudsley NHS Foundation Trust, London, UK.
Nilforooshan R; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Neuropsychiatr Dis Treat ; 19: 433-441, 2023.

Article em En | MEDLINE | ID: mdl-36861011

Palavras-chave

MDD; TRD; antidepressant; depression; glutamate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article